Literature DB >> 1309982

The phospholamban phosphatase associated with cardiac sarcoplasmic reticulum is a type 1 enzyme.

N A Steenaart1, J R Ganim, J Di Salvo, E G Kranias.   

Abstract

Canine cardiac sarcoplasmic reticulum vesicles contain intrinsic protein phosphatase activity, which can dephosphorylate phospholamban and regulate calcium transport. This phosphatase has been suggested to be a mixture of both type 1 and type 2 enzymes (E. G. Kranias and J. Di Salvo, 1986, J. Biol. Chem. 261, 10,029-10,032). In the present study the sarcoplasmic reticulum phosphatase activity was solubilized with n-octyl-beta-D-glucopyranoside and purified by sequential chromatography on DEAE-Sephacel, polylysine-agarose, heparin-agarose, and DEAE-Sephadex. A single peak of phosphatase activity was eluted from each column and it was coincident for both phospholamban and phosphorylase a, used as substrates. The partially purified phosphatase could dephosphorylate the sites on phospholamban phosphorylated by either cAMP-dependent or calcium-calmodulin-dependent protein kinase(s). Enzymatic activity was inhibited by inhibitor-2 and by okadaic acid (I50 = 10-20 nM), using either phosphorylase a or phospholamban as substrates. The sensitivity of the phosphatase to inhibitor-2 or okadaic acid was similar for the two sites on phospholamban, phosphorylated by the cAMP-dependent and the calcium-calmodulin-dependent protein kinases. Phospholamban phosphatase activity was enhanced (40%) by Mg2+ or Mn2+ (3 mM) while Ca2+ (0.1-10 microM) had no effect. These characteristics suggest that the phosphatase associated with cardiac sarcoplasmic reticulum is a type 1 enzyme, and this activity may participate in the regulation of Ca2+ transport through dephosphorylation of phospholamban in cardiac muscle.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1309982     DOI: 10.1016/0003-9861(92)90359-5

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  29 in total

1.  Protein phosphatases decrease sarcoplasmic reticulum calcium content by stimulating calcium release in cardiac myocytes.

Authors:  Dmitry Terentyev; Serge Viatchenko-Karpinski; Inna Gyorke; Radmila Terentyeva; Sandor Gyorke
Journal:  J Physiol       Date:  2003-08-01       Impact factor: 5.182

2.  Deformation of the Bowditch staircase in Ca(2+)-overloaded mammalian cardiac tissue--a calcium phenomenon?

Authors:  M Löhn; G Szymanski; F Markwardt
Journal:  Mol Cell Biochem       Date:  1996 Jul-Aug       Impact factor: 3.396

3.  Dynamic modulation of excitation-contraction coupling by protein phosphatases in rat ventricular myocytes.

Authors:  W H duBell; W J Lederer; T B Rogers
Journal:  J Physiol       Date:  1996-06-15       Impact factor: 5.182

Review 4.  Gene therapy targets in heart failure: the path to translation.

Authors:  P W J Raake; H Tscheschner; J Reinkober; J Ritterhoff; H A Katus; W J Koch; P Most
Journal:  Clin Pharmacol Ther       Date:  2011-08-24       Impact factor: 6.875

5.  Phospholamban phosphorylation, mutation, and structural dynamics: a biophysical approach to understanding and treating cardiomyopathy.

Authors:  Naa-Adjeley D Ablorh; David D Thomas
Journal:  Biophys Rev       Date:  2015-01-21

Review 6.  Altered sarcoplasmic reticulum calcium cycling--targets for heart failure therapy.

Authors:  Changwon Kho; Ahyoung Lee; Roger J Hajjar
Journal:  Nat Rev Cardiol       Date:  2012-10-23       Impact factor: 32.419

7.  Partial purification and characterization of a type 1 protein phosphatase in purified nuclei of pea plumules.

Authors:  Y L Guo; S J Roux
Journal:  Biochem J       Date:  1996-11-01       Impact factor: 3.857

8.  The ATP and Mg2+ dependence of Na(+)-K(+)-2Cl- cotransport reflects a requirement for protein phosphorylation: studies using calyculin A.

Authors:  H C Palfrey; E B Pewitt
Journal:  Pflugers Arch       Date:  1993-11       Impact factor: 3.657

9.  Translation of Ser16 and Thr17 phosphorylation of phospholamban into Ca 2+-pump stimulation.

Authors:  W A Jackson; J Colyer
Journal:  Biochem J       Date:  1996-05-15       Impact factor: 3.857

10.  Characterization of the molecular form of cardiac phospholamban.

Authors:  J M Harrer; E G Kranias
Journal:  Mol Cell Biochem       Date:  1994-11-23       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.